MYC and B-cell non-Hodgkin lymphoma: Consistent with the complex genomic landscape and prevalence of genetic aberrations identified in EBL, the transcriptional analysis detected an enrichment of high-grade signatures, including c-MYC-related signaling, which is observed in aggressive variants of large B-cell lymphomas.